CellVec enters strategic partnership with Peter MacCallum Cancer Centre | Healthcare Asia Magazine
, APAC

CellVec enters strategic partnership with Peter MacCallum Cancer Centre

The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.

CellVec announced its strategic partnership with Australia's Peter MacCallum Cancer Centre (Peter Mac) on 30 September.

Peter Mac haematologist Professor Simon Harrison noted the partnership with CellVec will underpin and enable a pipeline of high-potential research focused on developing the next generation of cancer immunotherapies in the Asia Pacific.

"Lentiviral vectors are a critical component in the generation of advanced cell and gene therapies such as CAR-T cells, but the complexity in manufacture impacts quality, cost, and accessibility. Our CellVec Vector Platform seeks to address this by ensuring optimal process performance from helper and packaging construct expression to upstream and downstream processes, producing high-quality products," said CellVec Chief Scientific Officer Dr. Lucas Chan.

Established in 2018 within the regional biotechnology hub of Singapore, CellVec was awarded GMP certification in 2020 by the Health Sciences Authority.

Follow the links for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!